FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer
by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a
Updated on: November 07,2024
0

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer
by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a
Updated on:November 07,2024
0
